Recent Articles
Posted By: Michael C. Soulen, MD
Sat Sep 22nd, 2018
A collaboration among interventional oncologists pooling outcomes of 155 patients with neuroendocrine tumor liver metastases treated at seven cancer centers across the United States has won the CVIR Award for most highly cited article at the 2018 CIRSE Annual Meeting in Lisbon, Portugal.
Posted By: Michael C. Soulen, MD
Thu Jul 21st, 2016
Controversy erupted at the HCC Evidence-based Practice Debates at WCIO 2016 regarding combination therapy for HCC. Panelist, expert and author Karen Brown, MD from Memorial Sloan-Kettering Cancer Center responds:
Posted By: Michael C. Soulen, MD
Sat Apr 23rd, 2016
It was an exciting day at the Suzhou International Expo Center, where the 12th Asia-Pacific Congress of Cardiovascular & interventional Radiology (APCCVIR 2016) hosted joint sessions with SIR, CIRSE and WCIO.
Posted By: Michael C. Soulen, MD
Thu Sep 25th, 2014
As part of FDA’s work to prevent and mitigate drug shortages, the Agency created the FDA Drug Shortage Assistance Award to provide public recognition to drug companies and manufacturers who have demonstrated a commitment to preventing or alleviating drug shortages of medically necessary drugs.
Posted By: Michael C. Soulen, MD
Tue Jan 14th, 2014
Billboards and busses in Philadelphia abound with Blue Cross’ current Live Fearless campaign, most featuring healthy-looking young people engaged in vigorous activities. “Live in Fear” would be a better tagline for Blue Cross patients with liver metastases, as two of my recent patients discovered...
